• Info
  • Significant Ownership

Significant Ownership of Nantahala Capital Partners Limited Partnership

Signature - Title
/s/ Taki Vasilakis - Taki Vasilakis / Chief Compliance Officer Nantahala Capital Management, LLC
Location
New Canaan, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Nantahala Capital Partners Limited Partnership.

Notify me when Nantahala Capital Partners Limited Partnership files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Nantahala Capital Partners Limited Partnership

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EGRX Eagle Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 6.2% $1,588,835 810,630 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 16 Feb 2025
DRIO DarioHealth Corp. Common Stock, par value $0.0001 per share 5.8% $2,059,118 2,511,120 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 27 Feb 2025
NSPR InspireMD, Inc. Common Stock, par value $0.0001 per share 5.7% $5,827,419 2,418,016 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 30 Sep 2025
KPRX KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value 5.3% $569,115 189,705 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 08 Aug 2025
ABEO ABEONA THERAPEUTICS INC. Common Stock, $0.01 par value 5.1% $13,801,390 2,618,462 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 29 Sep 2025
DRIO DarioHealth Corp. Common Stock, par value $0.0001 per share 4.6% $5,491,128 316,497 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 30 Sep 2025
UNCY UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share 2.8% $1,895,683 -$3,073,653 3,009,021 -62% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 19 Dec 2024
SRZN Surrozen, Inc./DE Common Stock, $0.0001 par value per share 2.2% $740,658 -$1,032,581 73,918 -58% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 31 Mar 2025
SNTI Senti Biosciences, Inc. Common stock, par value $0.0001 per share 1.9% $1,592,925 +$637,170 502,500 +67% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 31 Mar 2025

Schedules 13D/G Reported by Nantahala Capital Partners Limited Partnership:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.